Hints and tips:
Related Special Reports
...UBSO: 6; L: 7; I: 7; Total: 20The legal team at the bank advised on the sale of UBS and Mitsubishi’s joint venture, Mitsubishi Corp-UBS Realty, to global investment fund KKR for $2bn....
...Medicago is majority owned by Mitsubishi Tanabe Pharma....
...Toshifumi Tada, head of vaccine business development at Mitsubishi Tanabe Pharma, said its subsidiary Medicago would apply for Canadian approval for its vaccine candidate that is made from a plant from the...
...Medicago, a unit of Mitsubishi Tanabe Pharma that is backed by Philip Morris International, is planning to launch the world’s first plant-based Covid-19 vaccine that is potentially cheaper and easier to...
...Takeda Pharmaceutical has no plans to seek approval in Japan for its dengue fever vaccine, nor does Mitsubishi Tanabe Pharma for an inoculation derived from a tobacco leaf plant....
...Of others joined in the chase, including Mitsubishi Tanabe Pharma, I’rom Group and Takeda Pharmaceutical, the last offers the best chances....
...Tanabe Pharma and Ono Pharmaceutical, both founded three centuries ago....
...Shares in Mitsubishi Tanabe Pharma closed 1.2 per cent lower in Tokyo on Monday, a little more than double the decline for the broader Japanese stock market....
...“No other Japanese pharma company management team has that level of international experience.”...
...(NYT) A pharma M&A boom could boost innovation: With a wave of pharma mergers potentially on the horizon, companies may be set to unleash a new age of innovation....
...(Financial Times) Siemens and Mitsubishi raise stakes in Alstom bid battle: Siemens and Mitsubishi Heavy Industries have upped the stakes in their bidding war with General Electric over Alstom’s energy...
...(SFr1.60)News Corp Q4 $0.39 ($0.31)Old Mutual H1 (FY estimate) 18.97p (18.40p)Zynga Q2 $0.0 (-$0.01) Earnings Allianz Q2 €3.37 (€3.47)Softbank Q1 Y107.798 (n/a) Results forecasts, from Thomson Reuters,...
...Japan’s Daiichi Sankyo, Mitsubishi Tanabe Pharma and Fujifilm have also said they will enter the fray....
...Inpex fell 1.6 per cent to Y719,000, while Mitsubishi Corp fell 2.6 per cent to Y1,922....
...Mitsubishi declined 5.5 per cent to Y1,962 and Mitsui and Co shed 4.9 per cent to Y1,243. Astellas Pharma fell 6.7 per cent to Y3,340 after a broker downgrade....
...Pharma for $150m....
...Astellas Pharma rose by 4.2 per cent to Y3,210. However Sanyo fell by 0.7 per cent to Y139....
...Top holdings include NTT DoCoMo, East Japan Railway, Sumitomo Trust & Banking, Nippon Commercial, Astellas Pharma, Nintendo, Mitsubishi, JFE Holding, Daiwa Securities Group and Seven & I Holdings....
...Drug companies were some of the strongest performers on the Nikkei, with Astellas Pharma rallying 4.5 per cent to Y4,640, Takeda Pharmaceutical gaining 3.6 per cent to Y5,520....
...Sumitomo was down 3.0 per cent to Y1,391, Mitsubishi fell by 2.6 per cent to Y3,420 and Marubeni lost 2.2 per cent to Y887....
...Other companies it claimed to control on Friday were Mitsubishi Heavy Industries, Astellas Pharmaceuticals and Fuji Television....
...Mitsubishi slumped by 4.6 per cent to Y3,730, Mitsui lost 4.4 per cent to Y2,630 and Sumitomo was down 4.5 per cent to Y1,583. Australian shares were down on weaker oil and commodity prices....
...Among banks, Mitsubishi UFJ Financial fell by 3.7 per cent to Y1,117 and Mizuho Financial fell by 4.5 per cent to Y529,000. Sumitomo Trust & Banking lost 5.0 per cent to Y899....
...Mitsubishi Heavy fell 0.2 per cent to Y463....
...Tanabe was down 0.1 per cent to Y1,671, with Mitsubishi Pharma up only 0.7 per cent to Y813. These positive factors outweighed two corporate scandals....
International Edition